Русский
Russia intends to implement joint projects with China’s Eppen Group in amino acid production, as well as to cooperate in other areas of the agricultural industry. Oksana Lut, the Russian Agriculture Minister, has been on a working visit to China and stated that the respective Russian and Chinese parties discussed the prospects for collaboration.
She said that “One of today’s priorities of Russia’s agricultural sector is developing biotech production, including collaboration with international partners. China’s Ningxia Eppen Investment Group has in-house expertise in strain selection, fermentation, downstream processing, and technology transfer, as well as implementing projects in this area.”
Lut met with Ningxia Eppen Investment Group’s chairman of the board of directors, Yang Xiaoping, during the visit. Lut added that “The parties discussed implementing joint projects in amino acid production, as well as prospects to collaborate in other areas of the agricultural sector going forward. Our Chinese partners have confirmed their readiness to bolster collaboration in biotech and to promote developing scientific, engineering, and industrial bases in Russia and China.”
Biotechnology is a multidisciplinary field that combines biology, chemistry, physics, engineering, and computer science to harness living organisms or their components for practical applications. It involves manipulating biological systems—such as bacteria, yeast, plants, or animal cells—to produce useful substances, solve problems, or create new technologies. Modern biotechnology often relies on genetic engineering, which allows scientists to modify an organism’s DNA to achieve desired traits or produce therapeutic proteins.
The global biotech market was worth about US$1.77 trillion in 2025, with a growth trajectory to US$6.34 trillion by 2035. China is rapidly advancing in the biotech sector, driven by government incentives and a growing number of collaborations in biological sciences.
